Kimberly J. Popovits, President and CEO at GENOMIC HEALTH INC (GHDX), sold 99,600 shares at $65.41 ($6.5M) on 2018-10-16, disclosed to the SEC on 2018-10-17.
Seasonal sale ($6.5M) by President and CEO — this insider has traded GHDX in October in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.26 | 23,720 | $1.5M | 23.4% |
| 2 | $64.26 | 23,720 | $1.5M | 23.4% |
| 3 | $64.79 | 880 | $57K | 0.9% |
| 4 | $64.79 | 880 | $57K | 0.9% |
| 5 | $65.76 | 400 | $26K | 0.4% |
| 6 | $64.45 | 2,795 |
| $180K |
| 2.8% |
| 7 | $64.45 | 2,795 | $180K | 2.8% |
| 8 | $65.41 | 6,103 | $399K | 6.1% |
| 9 | $65.41 | 6,103 | $399K | 6.1% |
| 10 | $66.43 | 8,217 | $546K | 8.4% |
| 11 | $66.43 | 8,217 | $546K | 8.4% |
| 12 | $67.39 | 7,885 | $531K | 8.2% |
| 13 | $67.39 | 7,885 | $531K | 8.2% |
| Total | $65.28 avg | 99,600 | $6.5M | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $1.4M | — | Filing → |
| GHDX | SELL | 2019-08-14 | $7.4M | — | Filing → |
| GHDX | SELL | 2019-08-12 | $5.5M | — | Filing → |